Career history of Henrich R. K. Guntermann
Former positions of Henrich R. K. Guntermann
| Companies | Position | Start | End |
|---|---|---|---|
| CRESCITA THERAPEUTICS INC. | Director/Board Member | 29/02/2016 | 28/09/2016 |
| Corporate Officer/Principal | 29/02/2016 | 10/07/2016 | |
| NUVO PHARMACEUTICALS INC. | Director/Board Member | 20/09/2004 | 29/02/2016 |
| Corporate Officer/Principal | 15/12/2009 | 29/02/2016 | |
| President | 20/09/2004 | 15/12/2009 |
Training of Henrich R. K. Guntermann
| Philipps University of Marburg | Doctorate Degree |
Statistics
International
| Canada | 3 |
| Germany | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| President | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CRESCITA THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Nuvo Pharmaceuticals, Inc.
 Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada. | Health Technology |
